SB

Samsara BioCapital Portfolio holdings

AUM $969M
1-Year Est. Return 134.49%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+134.49%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$969M
AUM Growth
+$203M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
30
New
Increased
Reduced
Closed

Top Buys

1
+$48.2M
2
+$24.1M
3
+$12.8M
4
KLRS
Kalaris Therapeutics
KLRS
+$9.59M
5
XFOR icon
X4 Pharmaceuticals
XFOR
+$7.12M

Top Sells

1
+$16M
2
+$15.7M
3
+$10.3M
4
PVLA
Palvella Therapeutics
PVLA
+$8.94M
5
CTNM
Contineum Therapeutics
CTNM
+$5.69M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRZN icon
26
Surrozen
SRZN
$238M
– –
-241,400
SRZNW icon
27
Surrozen Inc Warrant
SRZNW
$63.6K
– –
-99,999
TERN icon
28
Terns Pharmaceuticals
TERN
$4.57B
– –
-135,573
ZYME icon
29
Zymeworks
ZYME
$1.76B
– –
-207,901
LENZ
30
LENZ Therapeutics
LENZ
$428M
– –
-343,012
1
2